BAXTER

Serial Number 98416599
Registration 7469039
700

Registration Progress

Application Filed
Feb 22, 2024
Under Examination
Approved for Publication
May 21, 2024
Published for Opposition
May 21, 2024
Registered
Aug 6, 2024

Basic Information

Serial Number
98416599
Registration Number
7469039
Filing Date
February 22, 2024
Registration Date
August 6, 2024
Published for Opposition
May 21, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 6, 2024
Registration
Registered
Classes
005

Rights Holder

Baxter International Inc.

03
Address
One Baxter Parkway
Deerfield, IL 60015

Ownership History

Baxter International Inc.

Original Applicant
03
Deerfield, IL

Baxter International Inc.

Owner at Publication
03
Deerfield, IL

Baxter International Inc.

Original Registrant
03
Deerfield, IL

Legal Representation

Attorney
Jeffrey Klembczyk

USPTO Deadlines

Next Renewal Deadline
1855 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-08-06)
Due Date
August 06, 2030
Grace Period Ends
February 06, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

19 events
Date Code Type Description
Apr 9, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 9, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 9, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 9, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 6, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 6, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
May 21, 2024 PUBO A PUBLISHED FOR OPPOSITION
May 21, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 1, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 16, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 12, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 12, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 11, 2024 GNRT F NON-FINAL ACTION E-MAILED
Apr 11, 2024 CNRT R NON-FINAL ACTION WRITTEN
Apr 11, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 8, 2024 DOCK D ASSIGNED TO EXAMINER
Feb 26, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical products, namely, injection solutions for human use in the treatment of cardiovascular disease; preparations for human health care in the treatment of cardiovascular disease; cardiovascular pharmaceutical preparations; local anesthetics for human use; inhalant anesthetic; pharmaceutical preparations for the induction of local anesthesia; general anesthetics for human use; transdermal patches featuring scopolamine for treatment of nausea and vomiting; antibiotics for human use; sedatives for human use; injectable pharmaceuticals for treatment of infections, bacterial infections, viral infections, pain, fever, hypertension, low blood pressure, heart disease, chest pain, hemodynamic imbalances, blood clots, ulcers, ventricular fibrillation, yeast infections, fungal infections, heart failure, diabetes, cancer, nausea and vomiting, edema, constipation, cirrhosis, opioid overdose, poisoning, heavy bleeding, dehydration, swelling, low magnesium, acne, rapid heartbeats, and low calcium; prescription medicines, namely, pills, tablets, capsules and pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention of nausea, vomiting, and damage to bladder; pharmaceutical preparations to temporarily arrest the heart; pharmaceutical preparations for use in cardiac rhythm support; potassium preparations for pharmaceutical purposes; insulin; pharmaceutical preparations, namely, irrigation solutions for flushing, rinsing and cleansing of body tissues, body cavities, and wounds; medical instruments, namely, medical containers and medical bags sold filled with medical liquids and solutions, namely, irrigation solutions for cleansing wounds; amino acid preparations for medical purposes; liquid nutritional supplement; liquid vitamin supplements; saline solution for medical purposes; sterile water for medical purposes
First Use Anywhere: Jan 1, 2023
First Use in Commerce: Jan 1, 2023

Classification

International Classes
005